1. Simpson E, Santen RJ. Celebrating 75 years of oestradiol. J Mol Endocrinol. 2015 Dec;55(3):T1–20.
2. Dietel M, Lewis MA, Shapiro S. Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review. Hum Reprod. 2005;20:2052–60.
3. Rossouw JE, Andersen JL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogens plus progestin in healthy postmenopausal women: principal results from the Women‘s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.
4. Wharton W, Gleason CE, Miller VN, Asthana S. Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog). Brain Res. 2013 Jun 13;1514:12–7.
5. Mosekilde L, Hermann AP, Beck-Nielsen H, Charles P, Pars-Nielsen S, Helmer Sorensen O. The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2,000 normal perimenopausal women. Maturitas. 1990 March 15;31(3):207–19.